Herceptin drug and breast cancer cell. Molecular model of Herceptin (Trastuzumab), showing the molecule's secondary structure, seen as alpha helices (
Herceptin drug and breast cancer cell. Molecular model of Herceptin (Trastuzumab), showing the molecule's secondary structure, seen as alpha helices (coils) and beta sheets (arrows). A coloured scanning electron micrograph (SEM) of a breast cancer cell is at lower left (blue). Herceptin binds to HER2 (human epidermal growth factor receptor 2), a receptor that is over-expressed in some breast cancer cells, making them grow faster and more likely to spread. Herceptin blocks HER2, which kills the breast cancer cells. Around a fifth of breast cancers result from cells that over-express HER2, making them viable for Herceptin treatment.
Size: 4724px × 4724px
Photo credit: © ALFRED PASIEKA/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: 2, abnormal, alpha, antibody, artwork, balls, beta, biochemical, biochemistry, biological, biology, breast, cancer, cancerous, cell, chemical, chemistry, chemotherapy, colored, coloured, composite, compound, compounds, cut, cut-, cutout, dots, drug, epidermal, factor, growth, helices, helix, helixes, her2, herceptin, human, illustration, immunology, malignancy, malignant, medical, medicine, model, molecular, molecule, molecules, monoclonal, oncology, person, pharmacological, pharmacology, protein, proteins, receptor, secondary, sem, sheet, sheets, structure, therapy, trastuzumab, treatment, tumour, unhealthy
